| Literature DB >> 32759766 |
Martynas Talaikis1, Simona Strazdaitė2, Mantas Žiaunys3, Gediminas Niaura2.
Abstract
Several neurodegenerative diseases, like Alzheimer's and Parkinson's are linked with protein aggregation into amyloid fibrils. Conformational changes of native protein into the β-sheet structure are associated with a significant change in the vibrational spectrum. This is especially true for amide bands which are inherently sensitive to the secondary structure of a protein. Raman amide bands are greatly intensified under resonance conditions, in the UV spectral range, allowing for the selective probing of the peptide backbone. In this work, we examine parallel β-sheet forming GGVVIA, the C-terminus segment of amyloid-β peptide, using UV-Vis, FTIR, and multiwavelength Raman spectroscopy. We find that amide bands are enhanced far from the expected UV range, i.e., at 442 nm. A reasonable two-fold relative intensity increase is observed for amide II mode (normalized according to the δCH2/δCH3 vibration) while comparing 442 and 633 nm excitations; an increase in relative intensity of other amide bands was also visible. The observed relative intensification of amide II, amide S, and amide III modes in the Raman spectrum recorded at 442 nm comparing with longer wavelength (633/785/830 nm) excited spectra allows unambiguous identification of amide bands in the complex Raman spectra of peptides and proteins containing the β-sheet structure.Entities:
Keywords: Raman spectroscopy; amide II; amyloid fibril; protein aggregation; secondary structure; β-sheet
Mesh:
Substances:
Year: 2020 PMID: 32759766 PMCID: PMC7435454 DOI: 10.3390/molecules25153556
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Molecular structure of amyloid-β-(37–42) motif, the GGVVIA (A). AFM image of aggregated GGVVIA peptide deposited on mica. Black arrows indicate peptide oligomers and white arrows indicate fibrils (B). FTIR spectra of aggregated (10 mg/mL) and non-aggregated (5 mg/mL) GGVVIA peptide in the amide I’ absorption region recorded in D2O solution (C). UV–Vis spectra of aggregated (10 mg/mL) and non-aggregated (0.01 mg/mL) GGVVIA peptide (D). Arrows indicate the wavelengths of laser radiation used in this study.
Figure 2Raman spectra of aggregated (20 gm/mL) GGVVIA peptide in H2O excited at 325, 442, 633, 785, and 830 nm (A) and Raman spectra of aggregated and non-aggregated (5 mg/mL) GGVVIA in H2O excited at 442 nm. Spectra are normalized with respect to the peak intensity at 1463 cm−1; the spectral intensity is retained in both (A) and (B) panels. The (C) panel shows the dependence of the enhancement factor of AII, AS, AI, and AIII3 bands on the excitation wavelengths.
Assignments of Raman spectral bands of aggregated GGVVIA peptide recorded at 325 nm excitation.
| Wavenumber, cm−1 | Assignment | References |
|---|---|---|
| 1124 | r(CH3), δ(CCH) | [ |
| 1231 | AIII3; β-sheet | [ |
| 1264 | AIII2 | [ |
| 1292 | AIII1 | [ |
| 1320 | tCH2, wCH2 | [ |
| 1346 | δCH2 | [ |
| 1396 | AS | [ |
| 1435 | δCH2 | [ |
| 1446 | δCH2 | [ |
| 1463 | δCH2, δCH3 | [ |
| 1558 | AII | [ |
| 1664 | AI; β-sheet | [ |
Abbreviations: r, rocking; t, twisting; w, wagging; δ, deformation.
Setup of the Raman system.
| Laser Line, nm | Power at Sample, mW | Grating, Lines/mm | Objective, Mag. (NA); Spectral Range |
|---|---|---|---|
| 325 | 4.3 | 3600 | Thor Labs, 15× (0.32); UV |
| 442 | 53 | 2400 | Leica, 5×, (0.12); Vis |
| 633 | 9.4 | 1200 | Leica, 5×, (0.12); Vis |
| 785 | 92 | 1200 | Olympus, 50× (0.65); IR |
| 830 | 166 | 830 | Olympus, 50× (0.65); IR |